Interpretation of an oral test on glucose tolerance

被引：0
作者：
Hanefeld, Markolf [1 ]
Koehler, Carsta [1 ]
机构：
[1] GWT TUD GmbH, Zentrum Klin Studien Forsch Bereich Stoffwechsel, D-01307 Dresden, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2009年 / 134卷 / 06期
关键词：
DIABETES-MELLITUS; DIAGNOSIS;
D O I：
10.1055/s-0028-1123992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：266 / 266
页数：1
相关论文
共 6 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[4]   Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in an at-risk population:: data from the RIAD study using new diagnostic criteria [J].
Köhler, C ;
Temelkova-Kurktschiev, T ;
Schaper, F ;
Fücker, K ;
Hanefeld, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (37) :1057-1061
[5]   Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study [J].
Norhammar, A ;
Tenerz, Å ;
Nilsson, G ;
Hamsten, A ;
Efendíc, S ;
Rydén, L ;
Malmberg, K .
LANCET, 2002, 359 (9324) :2140-2144
[6]   Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply [J].
Ryden, Lars ;
Standl, Eberhard .
EUROPEAN HEART JOURNAL, 2007, 28 (11) :1402-1402
1